VRTX logo

VRTX return on equity

annual ROE:

-3.15%-26.14%(-113.70%)
December 31, 2024

Summary

  • As of today (August 20, 2025), VRTX annual return on equity is -3.15%, with the most recent change of -26.14% (-113.70%) on December 31, 2024.
  • During the last 3 years, VRTX annual ROE has fallen by -28.08% (-112.64%).
  • VRTX annual ROE is now -104.89% below its all-time high of 64.43%, reached on December 31, 2018.

Performance

VRTX ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRTXprofitability metrics

quarterly ROE:

22.60%+28.64%(+474.17%)
June 30, 2025

Summary

  • As of today (August 20, 2025), VRTX quarterly return on equity is 22.60%, with the most recent change of +28.64% (+474.17%) on June 30, 2025.
  • Over the past year, VRTX quarterly ROE has increased by +25.56% (+863.51%).
  • VRTX quarterly ROE is now -68.47% below its all-time high of 71.67%, reached on December 31, 2018.

Performance

VRTX quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRTXprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

VRTX ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-113.7%+863.5%
3 y3 years-112.6%-26.9%
5 y5 years-114.1%-34.0%

VRTX ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-111.4%at low-26.9%+474.2%
5 y5-year-108.6%at low-43.8%+474.2%
alltimeall time-104.9%+98.3%-68.5%+107.8%

VRTX ROE History

DateAnnualQuarterly
Jun 2025
-
22.60%(-474.2%)
Mar 2025
-
-6.04%(+87.0%)
Dec 2024
-3.15%(-113.7%)
-3.23%(+11.8%)
Sep 2024
-
-2.89%(-2.4%)
Jun 2024
-
-2.96%(-112.2%)
Mar 2024
-
24.35%(+4.8%)
Dec 2023
22.99%(-16.9%)
23.23%(-1.8%)
Sep 2023
-
23.65%(-3.3%)
Jun 2023
-
24.46%(-3.6%)
Mar 2023
-
25.38%(-8.5%)
Dec 2022
27.67%(+11.0%)
27.74%(-5.9%)
Sep 2022
-
29.49%(-4.6%)
Jun 2022
-
30.92%(+22.9%)
Mar 2022
-
25.16%(-0.1%)
Dec 2021
24.93%(-32.1%)
25.19%(+3.1%)
Sep 2021
-
24.44%(+4.4%)
Jun 2021
-
23.42%(-32.5%)
Mar 2021
-
34.72%(-5.5%)
Dec 2020
36.71%(+64.1%)
36.76%(-8.6%)
Sep 2020
-
40.22%(+17.5%)
Jun 2020
-
34.24%(+25.1%)
Mar 2020
-
27.38%(+19.0%)
Dec 2019
22.37%(-65.3%)
23.01%(-51.3%)
Sep 2019
-
47.25%(-14.2%)
Jun 2019
-
55.07%(-10.8%)
Mar 2019
-
61.72%(-13.9%)
Dec 2018
64.43%(+1093.1%)
71.67%(+157.4%)
Sep 2018
-
27.84%(+147.5%)
Jun 2018
-
11.25%(+219.6%)
Mar 2018
-
3.52%(-32.6%)
Dec 2017
5.40%(-178.1%)
5.22%(+392.5%)
Sep 2017
-
1.06%(-94.3%)
Jun 2017
-
18.48%(+19.7%)
Mar 2017
-
15.44%(-317.8%)
Dec 2016
-6.91%(-87.1%)
-7.09%(-57.3%)
Sep 2016
-
-16.62%(-24.6%)
Jun 2016
-
-22.03%(-45.0%)
Mar 2016
-
-40.07%(-27.8%)
Dec 2015
-53.72%(-11.2%)
-55.53%(-14.0%)
Sep 2015
-
-64.58%(-8.3%)
Jun 2015
-
-70.41%(+12.3%)
Mar 2015
-
-62.69%(+1.5%)
Dec 2014
-60.49%(+14.0%)
-61.75%(+5.9%)
Sep 2014
-
-58.29%(+12.4%)
Jun 2014
-
-51.88%(+12.7%)
Mar 2014
-
-46.02%(-11.6%)
Dec 2013
-53.08%(+1041.5%)
-52.06%(+16.7%)
Sep 2013
-
-44.62%(+16.8%)
Jun 2013
-
-38.20%(-1.5%)
Mar 2013
-
-38.77%(+765.4%)
Dec 2012
-4.65%(-183.6%)
-4.48%(-122.2%)
Sep 2012
-
20.14%(-61.2%)
Jun 2012
-
51.91%(+25.3%)
Mar 2012
-
41.43%(+550.4%)
Dec 2011
5.56%(-105.9%)
6.37%(-110.5%)
Sep 2011
-
-60.44%(-55.4%)
Jun 2011
-
-135.50%(+19.1%)
Mar 2011
-
-113.79%(+22.7%)
Dec 2010
-94.31%(-2.0%)
-92.75%(+5.6%)
Sep 2010
-
-87.81%(+10.9%)
Jun 2010
-
-79.20%(+1.5%)
Mar 2010
-
-78.03%(-17.9%)
Dec 2009
-96.19%(-46.6%)
-95.00%(-20.1%)
Sep 2009
-
-118.83%(-11.2%)
Jun 2009
-
-133.87%(-6.4%)
Mar 2009
-
-143.05%(-12.6%)
Dec 2008
-180.27%
-163.74%(+21.6%)
Sep 2008
-
-134.66%(+10.6%)
Jun 2008
-
-121.71%(+9.1%)
DateAnnualQuarterly
Mar 2008
-
-111.52%(+15.4%)
Dec 2007
-100.69%(+80.4%)
-96.61%(+31.3%)
Sep 2007
-
-73.59%(+11.6%)
Jun 2007
-
-65.96%(+6.8%)
Mar 2007
-
-61.76%(-1.3%)
Dec 2006
-55.81%(-62.3%)
-62.60%(-26.3%)
Sep 2006
-
-84.90%(-37.8%)
Jun 2006
-
-136.44%(-6.4%)
Mar 2006
-
-145.74%(-25.1%)
Dec 2005
-148.15%(+1.7%)
-194.70%(-33.1%)
Sep 2005
-
-290.95%(+16.4%)
Jun 2005
-
-249.98%(+8.1%)
Mar 2005
-
-231.28%(+58.6%)
Dec 2004
-145.65%(+56.2%)
-145.83%(+36.3%)
Sep 2004
-
-106.96%(+1.7%)
Jun 2004
-
-105.21%(+6.0%)
Mar 2004
-
-99.28%(+53.6%)
Dec 2003
-93.25%(+266.5%)
-64.65%(+19.2%)
Sep 2003
-
-54.23%(+55.8%)
Jun 2003
-
-34.80%(+118.9%)
Mar 2003
-
-15.90%(-37.1%)
Dec 2002
-25.44%(+60.3%)
-25.27%(+26.0%)
Sep 2002
-
-20.06%(+3.7%)
Jun 2002
-
-19.35%(+9.3%)
Mar 2002
-
-17.71%(+17.1%)
Dec 2001
-15.87%(+29.7%)
-15.12%(+7.6%)
Sep 2001
-
-14.05%(-5.6%)
Jun 2001
-
-14.88%(+83.3%)
Mar 2001
-
-8.12%(-33.5%)
Dec 2000
-12.24%(-32.0%)
-12.21%(-2.2%)
Sep 2000
-
-12.48%(+64.4%)
Jun 2000
-
-7.59%(-59.1%)
Mar 2000
-
-18.57%(+0.7%)
Dec 1999
-17.99%(+42.0%)
-18.45%(-22.6%)
Sep 1999
-
-23.83%(+33.6%)
Jun 1999
-
-17.84%(+6.7%)
Mar 1999
-
-16.72%(+30.5%)
Dec 1998
-12.67%(+29.9%)
-12.81%(+26.2%)
Sep 1998
-
-10.15%(-9.9%)
Jun 1998
-
-11.27%(+39.0%)
Mar 1998
-
-8.11%(+1.9%)
Dec 1997
-9.75%(-73.7%)
-7.96%(+3.6%)
Sep 1997
-
-7.68%(-21.6%)
Jun 1997
-
-9.80%(-65.2%)
Mar 1997
-
-28.17%(-31.0%)
Dec 1996
-37.02%(+64.0%)
-40.82%(-1.6%)
Sep 1996
-
-41.49%(-10.7%)
Jun 1996
-
-46.48%(+70.0%)
Mar 1996
-
-27.34%(+20.0%)
Dec 1995
-22.57%(-0.6%)
-22.78%(-14.4%)
Sep 1995
-
-26.61%(+16.5%)
Jun 1995
-
-22.84%(+21.4%)
Mar 1995
-
-18.82%(-2.5%)
Dec 1994
-22.70%(-620.6%)
-19.30%(+284.5%)
Sep 1994
-
-5.02%(+25.2%)
Jun 1994
-
-4.01%(-211.7%)
Mar 1994
-
3.59%(-17.7%)
Dec 1993
4.36%(-124.7%)
4.36%(-119.7%)
Sep 1993
-
-22.11%(+9.5%)
Jun 1993
-
-20.20%(-7.9%)
Mar 1993
-
-21.94%(+26.3%)
Dec 1992
-17.67%(-0.6%)
-17.37%(+12.0%)
Sep 1992
-
-15.51%(-6.0%)
Jun 1992
-
-16.50%(-17.0%)
Mar 1992
-
-19.87%(-14.5%)
Dec 1991
-17.77%(-78.5%)
-23.23%(-43.7%)
Sep 1991
-
-41.29%(-66.5%)
Jun 1991
-
-123.08%(+42.2%)
Mar 1991
-
-86.54%(+4.7%)
Dec 1990
-82.69%
-82.69%

FAQ

  • What is Vertex Pharmaceuticals Incorporated annual return on equity?
  • What is the all time high annual ROE for Vertex Pharmaceuticals Incorporated?
  • What is Vertex Pharmaceuticals Incorporated annual ROE year-on-year change?
  • What is Vertex Pharmaceuticals Incorporated quarterly return on equity?
  • What is the all time high quarterly ROE for Vertex Pharmaceuticals Incorporated?
  • What is Vertex Pharmaceuticals Incorporated quarterly ROE year-on-year change?

What is Vertex Pharmaceuticals Incorporated annual return on equity?

The current annual ROE of VRTX is -3.15%

What is the all time high annual ROE for Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated all-time high annual return on equity is 64.43%

What is Vertex Pharmaceuticals Incorporated annual ROE year-on-year change?

Over the past year, VRTX annual return on equity has changed by -26.14% (-113.70%)

What is Vertex Pharmaceuticals Incorporated quarterly return on equity?

The current quarterly ROE of VRTX is 22.60%

What is the all time high quarterly ROE for Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated all-time high quarterly return on equity is 71.67%

What is Vertex Pharmaceuticals Incorporated quarterly ROE year-on-year change?

Over the past year, VRTX quarterly return on equity has changed by +25.56% (+863.51%)
On this page